Streetbeat News

Price Targets

ANGI

ASTS

ATUS

AUR

DISH

GSAT

INDI

QQQ

SMTC

VSAT

Analysts have identified nine U.S. tech stocks trading at a discount of over 40% from their 1-year forward average price targets, suggesting potential upsides of over 80%. These stocks are AST SpaceMobile, Inc. (ASTS), Globalstar, Inc. (GSAT), DISH Network Corporation (DISH), Altice USA, Inc. (ATUS), Semtech Corporation (SMTC), Viasat, Inc. (VSAT), Aurora Innovation, Inc. (AUR), Angi Inc. (ANGI), and indie Semiconductor, Inc. (INDI). The Invesco QQQ Trust (QQQ) tracks the Nasdaq 100, which has seen significant growth. Investors are reminded to exercise due diligence and maintain a balanced portfolio.

Portfolio Pulse from Piero Cingari

November 27, 2023 | 5:00 pm

ROKU

Over the last 3 months, 17 Wall Street analysts have provided ratings for Roku (NASDAQ:ROKU), with an average price target of $90.88, which is below the current price of $102.14, suggesting a downside. The ratings include 4 bullish, 5 somewhat bullish, and 8 indifferent, with no bearish or somewhat bearish ratings. The current average price target has increased by 4.36% from the previous target of $87.08. Analysts derive their ratings from various sources, including company calls, financial statements, and insider information.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 5:00 pm

DPZ

Over the past 3 months, 19 Wall Street analysts have published their ratings on Domino's Pizza (NYSE:DPZ), with an average 12-month price target of $420.84, a slight decrease from the previous target of $424.42. The ratings include 2 bullish, 11 somewhat bullish, 5 indifferent, and 1 somewhat bearish, with no bearish ratings. Analysts typically update their ratings quarterly and consider various factors including company financials, conference calls, and insider communications.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 5:00 pm

FRT

Evercore ISI Group has upgraded Federal Realty Investment Trust (NYSE:FRT) to Outperform with a new price target of $108.00, up from $104.00. The upgrade suggests a potential upside of 17.25% from the current share price of $92.11. Federal Realty Investment Trust specializes in high-quality retail properties in major metropolitan markets, with a portfolio that includes 102 properties with retail space and multifamily units.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 5:00 pm

EPR

EPR Properties (NYSE:EPR) has received mixed analyst ratings in the last quarter, with 1 somewhat bullish, 2 indifferent, and 1 somewhat bearish rating. The average 12-month price target for EPR is $45.5, which is a decrease of 11.36% from the previous target of $51.33. Analysts provide ratings based on financial analysis and company insights, and these ratings can influence investor decisions.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 5:00 pm

TRDA

HC Wainwright & Co. has maintained a Buy rating for Entrada Therapeutics (NASDAQ:TRDA) but lowered its price target from $25.00 to $20.00. Entrada's shares are currently trading at $11.51, and the new price target suggests a potential upside of 73.76%. Entrada focuses on developing intracellular biologics for treating devastating diseases.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 5:00 pm

RH

Wells Fargo has maintained its Overweight rating on RH (NYSE:RH) but reduced its price target from $375.00 to $335.00. RH's shares are currently trading at $268.00, down 0.31% over the last 24 hours. The new price target suggests a potential upside of 25.0% from the current price. RH is a luxury retailer in the home furnishing industry, with a growing hospitality business and plans to expand its market with new offerings.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 5:00 pm

AVB

AvalonBay Communities (NYSE:AVB) has received 7 analyst ratings in the last quarter, with an average price target of $192.71, representing an upside from the current price of $172.565. The ratings include 2 bullish, 2 somewhat bullish, and 3 indifferent. The current average price target has decreased by 3.36% from the previous target of $199.40.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 5:00 pm

TEVA

UBS has upgraded Teva Pharmaceutical Industries (NYSE:TEVA) from a previous rating to Buy, with a new price target of $13.00, up from $11.00. Teva's shares have risen 2.62% in the last 24 hours to $9.80. The new price target suggests a potential upside of 32.65% from the current share price. Teva is a leading generic drug manufacturer with a significant market presence in North America, Europe, Japan, Russia, and Israel, and offers a range of generic and specialty drugs, as well as active pharmaceutical ingredients and contract manufacturing services.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 5:00 pm

DE

Over the past 3 months, 4 Wall Street analysts have published their opinions on Deere & Company (NYSE:DE), with 1 giving a bullish rating and 3 remaining indifferent. The average price target is $421.25, which is higher than the current price of $369, suggesting an implied upside. However, this target has decreased by 8.82% from the previous target of $462.00. Analyst ratings are based on company data, financial statements, and insider information, and are intended to predict stock performance.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 5:00 pm